UniProtKB/Swiss-Prot P21757: Variant p.Gly369Ser

Macrophage scavenger receptor types I and II
Gene: MSR1
Feedback?

Variant information Variant position:

369 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Serine (S) at position 369 (G369S, p.Gly369Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Found in a family with prostate cancer. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs776370129 [ dbSNP | Ensembl ]

Sequence information Variant position:

369 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

451 The length of the canonical sequence.
Location on the sequence:

KVRLVGGSGPHEGRVEILHS G QWGTICDDRWEVRVGQVVCR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KVRLVGGSGPHEGRVEILHSGQWGTICDDRWEVRVGQVVCR

Mouse                         TVRLVGGSGAHEGRVEIFHQGQWGTICDDRWDIRAGQVVCR

Bovine                        TVRLVGGSGPHEGRVEIFHEGQWGTVCDDRWELRGGLVVCR

Rabbit                        TVRLVGGRGPHEGRVEILHNGQWGTVCDDHWELRAGQVVCR

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 451	Macrophage scavenger receptor types I and II
Topological domain	77 – 451	Extracellular
Domain	350 – 450	SRCR
Alternative sequence	345 – 408	TPFTKVRLVGGSGPHEGRVEILHSGQWGTICDDRWEVRVGQVVCRSLGYPGVQAVHKAAHFGQG -> S. In isoform III.
Alternative sequence	359 – 451	Missing. In isoform II.

Literature citations
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
Xu J.; Zheng S.L.; Komiya A.; Mychaleckyj J.C.; Isaacs S.D.; Hu J.J.; Sterling D.; Lange E.M.; Hawkins G.A.; Turner A.; Ewing C.M.; Faith D.A.; Johnson J.R.; Suzuki H.; Bujnovszky P.; Wiley K.E.; DeMarzo A.M.; Bova G.S.; Chang B.; Hall M.C.; McCullough D.L.; Partin A.W.; Kassabian V.S.; Carpten J.D.; Bailey-Wilson J.E.; Trent J.M.; Ohar J.; Bleecker E.R.; Walsh P.C.; Isaacs W.B.; Meyers D.A.;
Nat. Genet. 32:321-325(2002)
Cited for: POSSIBLE INVOLVEMENT IN PC; VARIANTS ALA-36; TYR-41; ALA-113; TYR-174; ALA-275; SER-369 AND ARG-441;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.